Asia‐Inclusive Clinical Research and Development Enabled by Translational Science and Quantitative Clinical Pharmacology: Toward a Culture That Challenges the Status Quo

Access lag to innovative therapies in Asian populations continues to present a challenge to global health. Recent progressive changes in the global regulatory landscape, including newer guidelines, are enabling simultaneous global drug development and near‐simultaneous global drug registration. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Venkatakrishnan, Karthik, Gupta, Neeraj, Smith, Patrick F., Lin, Tiffany, Lineberry, Neil, Ishida, Tatiana, Wang, Lin, Rogge, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Tutorials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083990/
https://www.ncbi.nlm.nih.gov/pubmed/35342942
http://dx.doi.org/10.1002/cpt.2591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083990/
https://www.ncbi.nlm.nih.gov/pubmed/35342942
http://dx.doi.org/10.1002/cpt.2591

Ejemplares similares